The global COVID-19 diagnostics market is anticipated to grow at a significant CAGR during the forecast period. Based on the technology, the market is segmented into Polymerase Chain Reaction (PCR), Antibody or Enzyme-Linked Immunosorbent Assay (ELISA), Serology, and Others. The Polymerase Chain Reaction (PCR) and Antibody or Enzyme-Linked Immunosorbent Assay (ELISA) segment are likely to register considerable growth in the overall market during the forecast period. The segmental growth of the market is accredited to the accurate as well as timely results provided by the technologies.
Browse the full report description of "Global COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments and Reagents & Kits), By Technology (Polymerase Chain Reaction (PCR), Antibody or Enzyme-Linked Immunosorbent Assay (ELISA), Serology, and Others), By End-User (Hospitals, Diagnostic Centers & Urgent Care Clinics, Research Labs), and Forecast 2020-2026" at https://www.omrglobal.com/industry-reports/covid-19-diagnostics-market
ELISA is a test for the identification of a substance including an antigen in a liquid sample or wet sample using antibodies. It is used as an indicative apparatus in drug and plant pathology and a quality-control check in different sectors. It provides a colored product as outcome correlating the amount of analysis that is present in the original sample. ELISA test can be efficiently used for the diagnosis of COVID-19 as it can precisely aid in the qualitative detection of the COVID-19 IgG and IgM in human serum.
For instance, Epitope Diagnostics Inc., the US-based company offers its ideal ELISA kits for virus detection. KT-1032 EDI and KT-1033 EDI are the two kits offered by the company for the effective detection of COVID-19 in extreme and critical conditions. Thus, the availability of such advanced devices for the detection is likely to offer growth opportunities to the COVID-19 diagnostics market during the forecast period.
Besides, PCR is also projected to considerably contribute to the growth of the global COVID-19 diagnostics industry owing to its significance in clinical diagnostics as well as drug development, rising precision & personalized medicine trends, and technological advancement in PCR technology to generate accurate results. To diagnose and develop a treatment for such infectious diseases, innovative technologies play an important role. Real-time RT PCR Assays Panel are widely used for the detection of novel coronavirus across the globe. Along with it, PCR coupled with other new techniques such as Next-Generation Sequencing (NGS) is transforming the microbial research including microbiome sequencing. Hence, this is also likely to significantly register in the COVID-19 diagnostics market growth.
Global COVID-19 Diagnostics Market – Segmentation
By Type
By Technology
By End-User
Global COVID-19 Diagnostics Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/covid-19-diagnostics-market